Stockreport

aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis [Yahoo! Finance]

aTyr Pharma, Inc.  (ATYR) 
PDF engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will present two pos [Read more]